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address different aspects of the event, including registration, speak-
ers, food, decorations, communication, parking, arts and crafts,
vendor exhibits, activities, educational sessions, and budget and
funding. The event was a celebration of life for BMT survivors and
was registered with the National Cancer Survivor’s Day Organi-
zation 17th National Observance of Survivors. It was a forum for
survivors to share their experiences and stories and provided an
opportunity to acknowledge the contribution of families, friends,
BMT researchers, and health care providers who are dedicated to
supporting BMT cancer survivors in their ﬁght for life. Our pro-
gram theme was “Survivor’s Island,” with decorations of palm trees
and other island decor. The volunteers and committee members
donned matching mango shirts and greeted the attendees with leis,
goodie bags, and Survivors’ Day t-shirts as they arrived. Attendees
enjoyed popcorn, food, and a cake in their honor. Vendors lined
the hallways with their exhibits. An arts and crafts room provided
the survivors an opportunity to place their special mark on 2
canvases that will forever capture their special day. With the help
of our institution’s Volunteer Endowment for Patient Support
Program, donations from local businesses, and physician and staff
contributions, we were able to provide a fun-ﬁlled program that
concluded with many gifts given away to our guests. With the
endless support of so many, this event recognized our active,
productive BMT survivor population and was the ﬁrst of what we
envision to be an annual celebration for the BMT program.
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ADENOVIRUS INFECTION IN PEDIATRIC BONE MARROW TRANSPLAN-
TATION: NURSING CONSIDERATIONS
Stokyhuzen, A., Frey, M., Prasad, V. The Duke Pediatric Stem Cell
Transplant Program, Durham, NC.
Adenovirus is widely recognized as a signiﬁcant cause of morbid-
ity and mortality in the pediatric bone marrow transplantation
population. Allogeneic and stem cell transplantation are additional
risk factors that negatively impact patient outcomes. Adenovirus is
a common DNA virus that accounts for 5%-10% of pediatric
febrile illnesses. Most children will be infected by one of the
adenovirus serotypes by age 5 years. For the healthy child, symp-
toms are generally mild. In the immunocompromised patient,
infection can range from asymptomatic shedding of the virus to
fatal disease. Mortality in the immunosuppressed host can range
from 50% to 60%. Risk factors attributed to a higher risk of
invasive or disseminated disease are age, allogeneic transplantation,
GVHD, and 2 or more positive culture sites. Adenovirus viremia is
associated with severe disease and can lead to pneumonia, gastro-
enteritis, hepatitis, cystitis, myocarditis, and encephalitis. Diagno-
sis of adenovirus can be made by serology, viral culture, shell viral
culture, electron microscopy, PCR, or immunostain. Treatment
for adenovirus remains variable and is not standardized at present.
Ribavirin, gancyclovir, IVIG therapy, and, most recently, cidofavir
are available as treatment options. The virus is spread easily by
droplets or via the fecal-oral route. Health care professionals,
visitors, and families need the education and diligence to adhere to
all institutional and CDC infection control guidelines. The pur-
pose of this abstract is to (1) describe the pathophysiology of
adenovirus in the immunocompromised host, (2) describe the clin-
ical symptoms of infection and severe disease, (3) outline the
current diagnostic tests used in adenovirus detection, (4) review the
current treatment options for adenovirus, and (5) describe infec-
tion control and nursing practices that are used in the care of these
patients.
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THE SAFE ADMINISTRATION OF UNDILUTED ETOPOSIDE IN THE PE-
DIATRIC BLOOD AND MARROW TRANSPLANTATION PATIENT
Fisher, V.L., Kistler, K., Rowbottom, L., Hegyi, K., Heinrich, M.
Rainbow Babies and Children’s Hospital, Cleveland, OH.
Blood and marrow transplantation (BMT) is successfully used to
treat malignant and nonmalignant diseases and disorders. The
delivery of the preparative regimen requires a strong knowledge
base that includes the expertise in the administration of chemo-
therapy and side effects. We report the administration of undiluted
etoposide (Bedford Laboratories, Bedford, OH) in our transplan-
tation program with minimal complications. In our series of pa-
tients, the decision to use undiluted etoposide was made due to
restrictive ﬂuid parameters and the patient’s condition. We have
used undiluted etoposide in 5 pediatric BMT patients. All patients
had a central venous access device for the administration of the
chemotherapy agent. All patients received their chemotherapy via
a syringe pump. To prevent disintegration of the tubing during the
administration of undiluted etoposide, all patients had a “dry”
connection from the syringe pump to the syringe tubing and to the
CVAD access port. All patients had vital signs taken per our policy
of every 15 minutes for the ﬁrst hour of the infusion, then every 30
minutes for the second hour of the infusion, then hourly until the
infusion was completed, and then every 4 hours. All patients had
emergency medications readily available during the etoposide in-
fusion. All patients received undiluted etoposide as a 4-hour infu-
sion; in 2 of the 5 patients the infusion time was increased due to
grade 2 hypotension, which recovered by temporarily stopping the
infusion. Our experience suggests that undiluted etoposide can be
safely administered in pediatric BMT patients.
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UTILIZING THE TOWN MEETING FORUM TO INVOLVE CAREGIVERS OF
PEDIATRIC PATIENTS UNDERGOING BONE MARROW AND STEM CELL
TRANSPLANTATION
Talbert, G., Frey, M.A. Duke University Medical Center, Durham,
NC.
Caregivers of children undergoing bone marrow and stem cell
transplantation face unique and signiﬁcant challenges. The average
length of stay for patients on the Duke Pediatric Stem Cell Trans-
plantation Unit is often several months. Caregivers are required to
leave their homes and extended families in hope of a life-saving
transplantation for their child. They enter a strange environment
over which they have very little control. Parents often report
feelings of “helplessness” and “being at the mercy of others” during
this difﬁcult period of time.
In 2003 the Duke Pediatric Stem Cell Transplant inpatient unit
developed a weekly Town Meeting Program to address the needs
of caregivers during the inpatient phase of transplantation. Each
week the medical, nursing, and support teams hold a 1-hour in-
formal meeting on the inpatient unit to speciﬁcally address the
needs of the families. These meetings were created to provide a
relaxed forum in which caregivers are free to discuss issues and
make improvements on the unit. Caregivers can voice concerns,
provide positive feedback, and request assistance in problem-solv-
ing. The town meeting also serves as a forum for the clinical team
to share ideas and monitor the overall morale of the caregivers. All
families also receive the services of the social work team for per-
sonal issues and concerns. This forum has greatly improved parent
satisfaction on the unit.
The purpose of this abstract is to share The Duke Pediatric Stem
Cell Transplantation Unit town meeting design with other trans-
plantation centers, including (1) design and implementation of the
initial forum; (2) who, where, and when—which staff to involve,
where to hold meetings and the best time for them; (3) successful
facilitation of the town meeting; and (4) keeping the momentum—
how to keep the meeting fresh and productive.
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EMPOWERING BMT NURSES TO SPEAK UP AND BE HEARD
Rivera, Z.R., Neumann, J.L. University of Texas M.D. Anderson
Cancer Center, Houston, TX.
Treatment with blood and marrow transplantation (BMT) can be
overwhelming, and pretreatment patient expectations can be high.
Caring for BMT patients involves a multidisciplinary approach.
Development of multidisciplinary teams allow for communication
of the treatment plan including medicine, pharmacy, psychosocial,
and rehabilitation aspects of care and discussion of expectations as
the treatment progresses. Having all disciplines involved contrib-
utes to the most beneﬁcial outcome for the patient.
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